Madrigal Pharmaceuticals Inc YDO1-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 7:55 PM CET
99.96quote price arrow down-0.54 (-0.54%)
52 week range
86.10 - 107.75

...

Loading . . .

KEY STATS

  • Open98.78
  • Day High101.75
  • Day Low98.78
  • Prev Close100.50
  • 52 Week High107.75
  • 52 Week High Date01/27/21
  • 52 Week Low86.10
  • 52 Week Low Date01/06/21
  • Market Cap1,885.05M
  • Shares Out15.47M
  • 10 Day Average Volume3.92
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change31.42

RATIOS/PROFITABILITY

  • EPS (TTM)-10.72
  • P/E (TTM)-9.32
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Madrigal Pharmaceuticals Inc News

QUOTE FINDER

Related Video

VIDEO6:2006:20
Reddit playing a major role in biotech trading action, says Jefferies top health care analyst

Profile

MORE
Madrigal Pharmaceuticals, Inc., formerly Synta Pharmaceuticals Corp., is a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH). The Company's lead product, MGL-3196, is a Phase II-ready once-daily, oral, liver-directed selective thyroid hormone receptor-b (THR-b) agonist for the treatment of NASH, and...
Paul Friedman M.D.
Chairman
Marc Schneebaum
Chief Financial Officer
Address
200 Barr Harbor Dr Ste 400
Conshohocken, PA
19428-2978
United States